research alliance
BostonGene, Hokkaido University to Study Biomarkers of Response in HER2-Positive Breast Cancer
The collaborators aim to use BostonGene's algorithms and genomics tools to identify HER2-positive breast cancer patients likely to respond to certain therapies.
BostonGene, University of Miami Ink Precision Oncology Collaboration in High-Grade B-Cell Lymphoma
BostonGene will use its next-generation sequencing technologies to analyze tumor samples collected at Sylvester and help guide treatment selection accordingly.
BostonGene, Mater Research Partner on Follicular Lymphoma Biomarker Discovery
BostonGene said it will support Mater Research's efforts to develop biomarkers of advanced follicular lymphoma, a slow-growing form of non-Hodgkin lymphoma.
Actinium Pharmaceuticals, NCI Ink Research Agreement on Targeted Radiopharmaceutical
Under the CRADA, Actinium will provide Actimab-A for research conducted by institutions in NCI's clinical trial networks, and the NCI will oversee studies involving the drug.
Indivumed Sells Biospecimens Service Unit to CRO Crown Bioscience
JSR Life Sciences' Crown Bioscience will acquire Indivumed's biobank and associated network IndivuServ, while Indivumed will retain its therapeutic-focused IndivuType.